基本信息 产品详情 公司简介 推荐产品
网站主页 化工产品目录 医药中间体 原料药中间体 富马酸沃诺拉赞 富马酸沃诺拉赞
  • 富马酸沃诺拉赞

富马酸沃诺拉赞

Vonoprazan fumarate
陕西 更新日期:2018-07-24

XI’AN WANLONG PHARMACEUTICAL CO.,LTD

非会员
联系人:raffia chou
电话:029-81881044拨打
手机:13259794374 拨打
邮箱:raffiachou@hotmail.com

产品详情:

中文名称:
富马酸沃诺拉赞
英文名称:
Vonoprazan fumarate
CAS号:
1260141-27-2
产地:
陕西、西安
纯度规格:
≥99%

Item Name

Vonoprazan fumarate

CAS NO

1260141-27-2 

Introduction

Vonoprazan fumarate has a novel mechanism of action called potassium-competitive acid blockers (P-CABs) which competitively inhibits the binding the potassium ions to H+, K+-ATPase (also known as the proton pump) in the final step of gastric acid secretion in gastric parietal cells. Vonoprazan provides a strong and sustained acid section inhibitory effect. 

Application

Vonoprazan fumarate is indicated for the treatment of gastric ulcer, duodenal ulcer and reflux esophagitis.

Apparence

White Powder

Package

Aluminum Bag;Drums;Paper Box Outside

Shipment

FedEx;DHL;UPS;TNT;EMS;Sea;Air.

Payment

Western Union;T/T;Trade Assurance;L/C

Warranty

2 Years

Vonoprazan fumarate ;API;avtive pharmaceutical ingredients

公司简介

Xi’an Wanlong pharmaceutical Co., Ltd was founded in 1995 and it is comprehensive modern pharmaceutical enterprise which mainly produces formulations, API and intermediates. The company’s registered capital reaches CNY 75 million. The building area of company is over 2000000 square meters. All the work shops are compliant with GMP requirements. There are more than 700 employees including over 70 RD staffs,20 experienced production management people and 8 senior professional registration specialists. Having a dynamic, high-quality team, which ensures our company sustainable and stable development. We produce tablets, capsule, granules, injection and API, total 49 drug approval numbers and other intermediates. There are 4 API workshops, and two solid preparation plants, injection plants with GMP. Annual production capacity of 100 tons of raw material, solid dosage form annual output of 3 billion, injection annual output 1.3 billion bags. The drug products are widely used in the most

成立日期 (29年)
注册资本 7500.000000万
员工人数 500人以上
年营业额 ¥ 1亿以上
经营模式 工厂
主营行业 医药中间体,原料药

富马酸沃诺拉赞相关厂家报价 更多

  • Vonoprazan
  • Vonoprazan
  • 沧州恩科医药科技有限公司 VIP
  • 2024-04-25
  • 询价
内容声明
拨打电话 立即询价